Corvus Pharmaceuticals Inc
NASDAQ:CRVS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Corvus Pharmaceuticals Inc
NASDAQ:CRVS
|
US |
|
Propel Holdings Inc
TSX:PRL
|
CA |
|
GlobalData PLC
OTC:GLDAF
|
UK |
|
Grupo Profuturo SAB de CV
BMV:GPROFUT
|
MX |
|
K
|
Krungthai Card PCL
SET:KTC
|
TH |
|
Co-Diagnostics Inc
NASDAQ:CODX
|
US |
|
Unilever PLC
LSE:ULVR
|
UK |
|
H
|
Hextar Capital Bhd
KLSE:HEXCAP
|
MY |
|
T
|
Toyota Tsusho Corp
TSE:8015
|
JP |
|
Kyowa Kirin Co Ltd
OTC:KYKOY
|
JP |
|
P
|
Plaza Wires Ltd
NSE:PLAZACABLE
|
IN |
|
S
|
Sparebank 1 Ostlandet
OSE:SPOL
|
NO |
|
Ibiden Co Ltd
F:IBI
|
JP |
|
C
|
Canadian Imperial Bank of Commerce
SWB:CAI
|
CA |
|
Oxide Corp
TSE:6521
|
JP |
|
D
|
Dentsu Group Inc
OTC:DNTUF
|
JP |
|
D
|
Drax Group PLC
OTC:DRXGY
|
UK |
|
G
|
GEA Group AG
DUS:G1A
|
DE |
|
Dynasty Gold Corp
XTSX:DYG
|
CA |
|
Mobilezone Holding AG
SIX:MOZN
|
CH |
Bankruptcy Probability
Corvus Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Corvus Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Corvus Pharmaceuticals Inc
NASDAQ:CRVS
|
989.3m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
465.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
229.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
187.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
133.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
81.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.2B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
53B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
59.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
43.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Corvus Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Corvus Pharmaceuticals Inc has no debt.
You can find a full breakdown on its Balance Sheet.